Genomic Prediction and Genome-Wide Association Studies of Morphological Traits and Distraction Index in Korean Sapsaree Dogs

PTD-DBM therapy for hair loss is being developed by Dr. Kang-Yell Choi, with human testing planned in South Korea. Some clinics in the U.S. offer PTD-DBM/valproic acid therapy, but it hasn't completed trials yet.

PTD-DBM is being explored for hair regrowth by targeting CXXC5, with clinical trials expected after pre-clinical studies. Users express anticipation and skepticism about its effectiveness.

South Korea's president is advocating for hereditary hair loss to be covered by national health insurance due to its impact on mental health and daily functioning. The discussion highlights the societal pressure in South Korea regarding appearance and the potential benefits of treating hair loss to improve mental health.

SCUBE3, a protein linked to hair growth in moles, was discovered over 25 years ago and is being developed by Amplifica for potential hair loss treatment. Concerns exist about SCUBE3's association with cancer, as it is a protein that promotes cell growth, which could potentially trigger cancer development if used for hair growth therapy.

The conversation discusses hair loss treatments like minoxidil, finasteride, and dutasteride, with some users expressing a willingness to use these despite potential risks. It also touches on societal pressures and discrimination faced by bald men, particularly in South Korea.

A user is developing an app called Follicle to track hairline changes using facial landmarks and inter-pupillary distance for standardization. The app aims to provide a more consistent way for consumers to monitor hairline changes over time.